ArticleClinical kidney journal2025

Clinical outcomes in Fabry patients switching to agalsidase beta for renal ineffectiveness of the primary Fabry therapy: a single-centre analysis.

Eleonora Riccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.